Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. C. Susca
In Vitro Efficacy of ARQ 092, an Allosteric AKT Inhibitor, on Primary Fibroblast Cells Derived From Patients With PIK3CA-related Overgrowth Spectrum (PROS)
Neurogenetics
Molecular Neuroscience
Genetics
Cellular
Related publications
Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors
PLoS ONE
Multidisciplinary
One of the First Cases With PIK3CA-related Overgrowth Spectrum (PROS) in Saudi Arabia: A Case Report and Literature Review
Cureus
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination With Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer
Cancer Research
Cancer Research
Oncology
Rapid Isolation and Expansion of Skin-Derived Precursor Cells From Human Primary Fibroblast Cultures
Biology Open
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
The Impact of Cetuximab Plus AKT- Or mTOR- Inhibitor in a Patient-Derived Colon Cancer Cell Model With Wild-Type RAS and PIK3CA Mutation
Journal of Cancer
Oncology
Biphasic Ability of Periosteum-Derived Cells Between Osteoblastgenesis and Fibroblast Genesis in Vitro
Clinical Oral Implants Research
Oral Surgery
Phase II Study of an AKT Inhibitor MK2206 in Patients With Relapsed or Refractory Lymphoma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Metabolic Consequences of Treatment With AKT Inhibitor Perifosine in Breast Cancer Cells
NMR in Biomedicine
Nuclear Medicine
Radiology
Molecular Medicine
Imaging
Spectroscopy
Effects of Antifibroblast Antiserum on Cells Derived From Fibroblast Outgrowth of Human Prostatic Tissues
